New direction of tumor immunotherapy

[SY6-4] T-cell therapies for leukemia and lymphoma: Beyond CARs

Catherine M. Bollard (Cancer and Immunology Research, Children's National Medical Center/George Washington University, USA)

Positions:
2013-present Director, Center for Cancer and Immunology Research, Children’s Research Institute, Children’s National Health System (CNHS), Washington, DC
2014-present Director, Program for Cell Enhancement and Technologies for Immunotherapy (CETI), CNHS, Washington, DC
2014-present Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine (Tenured), The George Washington University School of Medicine and Health Sciences, Washington, DC
Honors and Awards:
2010 Induction into the American Society for Clinical Investigation (ASCI)
2010-present Board of Directors, Foundation for the Accreditation of Cellular Therapy (FACT)
2012-2017 Chair, Non-Hodgkin’s Lymphoma Committee, Children’s Oncology Group (COG)
2013-2017 Board of Directors, American Society for Blood and Marrow Transplantation (ASBMT)
2013-present Member, Gene/Cell Therapy DSMB, National Heart Lung and Blood Institute (NHLBI)
2015-present Member, Cellular, Tissues and Gene Therapies Advisory Committee, FDA
2016-2018 President, International Society for Cellular Therapy (ISCT)